Related Experiment Video
Updated: May 21, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 13, 2014
NF-κB inhibition delays DNA damage-induced senescence and aging in mice
Jeremy S Tilstra1, Andria R Robinson, Jin Wang
1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract:
The accumulation of cellular damage, including DNA damage, is thought to contribute to aging-related degenerative changes, but how damage drives aging is unknown. XFE progeroid syndrome is a disease of accelerated aging caused by a defect in DNA repair. NF-κB, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases. To determine whether NF-κB drives aging in response to the accumulation of spontaneous, endogenous DNA damage, we measured the activation of NF-κB in WT and progeroid model mice. As both WT and progeroid mice aged, NF-κB was activated stochastically in a variety of cell types. Genetic depletion of one allele of the p65 subunit of NF-κB or treatment with a pharmacological inhibitor of the NF-κB-activating kinase, IKK, delayed the age-related symptoms and pathologies of progeroid mice. Additionally, inhibition of NF-κB reduced oxidative DNA damage and stress and delayed cellular senescence. These results indicate that the mechanism by which DNA damage drives aging is due in part to NF-κB activation. IKK/NF-κB inhibitors are sufficient to attenuate this damage and could provide clinical benefit for degenerative changes associated with accelerated aging disorders and normal aging.
Insights
Cellular DNA damage accumulation drives aging partly through activating NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells). Inhibiting this pathway delays aging symptoms and reduces DNA damage.
Area of Science:
- Molecular Biology
- Genetics
- Gerontology
Background:
- Cellular damage, particularly DNA damage, is linked to aging, but the underlying mechanisms remain unclear.
- Accelerated aging diseases like XFE progeroid syndrome stem from DNA repair defects.
- Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is activated by stress and shows increased activity with aging.
Purpose of the Study:
- To investigate if NF-κB activation, driven by endogenous DNA damage, contributes to aging.
- To explore the role of NF-κB in the aging process using progeroid mouse models.
Main Methods:
- Measured NF-κB activation in wild-type (WT) and progeroid model mice during aging.
- Utilized genetic depletion of the NF-κB p65 subunit.
- Administered pharmacological inhibitors of the NF-κB-activating kinase, IKK.
Main Results:
- NF-κB activation occurred stochastically in various cell types as mice aged.
- Genetic or pharmacological inhibition of NF-κB delayed age-related symptoms and pathologies in progeroid mice.
- NF-κB inhibition reduced oxidative DNA damage, stress, and delayed cellular senescence.
Conclusions:
- DNA damage contributes to aging, in part, through NF-κB activation.
- Inhibitors targeting the IKK/NF-κB pathway can mitigate age-related damage.
- IKK/NF-κB inhibitors show potential for treating accelerated aging disorders and normal aging processes.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity